Assessment of Supplementation with Different Biomolecules in the Prevention and Treatment of COVID-19
-
Published:2024-09-11
Issue:18
Volume:16
Page:3070
-
ISSN:2072-6643
-
Container-title:Nutrients
-
language:en
-
Short-container-title:Nutrients
Author:
González-Acedo Anabel1ORCID, Manzano-Moreno Francisco Javier23ORCID, García-Recio Enrique13ORCID, Ruiz Concepción134ORCID, Luna-Bertos Elvira de13ORCID, Costela-Ruiz Víctor Javier13ORCID
Affiliation:
1. Biomedical Group (BIO277), Department of Nursing, Faculty of Health Sciences, University of Granada, Avda. Ilustración 60, 18016 Granada, Spain 2. Biomedical Group (BIO277), Department of Stomatology, School of Dentistry, University of Granada, 18016 Granada, Spain 3. Institute of Biosanitary Research, ibs.Granada, Avda. de Madrid, 15 Pabellón de Consultas Externas, 2ª Planta, 18012 Granada, Spain 4. Institute of Neuroscience, University of Granada, 18016 Granada, Spain
Abstract
Consequences of the disease produced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have led to an urgent search for preventive and therapeutic strategies. Besides drug treatments, proposals have been made for supplementation with biomolecules possessing immunomodulatory and antioxidant properties. The objective of this study was to review published evidence on the clinical usefulness of supplementation with vitamin D, antioxidant vitamins (vitamin A, vitamin E, and vitamin C), melatonin, lactoferrin and natural products found in food (curcumin, luteolin, ginger, allicin, magnesium and zinc) as supplements in SARS-CoV-2 infection. In general, supplementation of conventional treatments with these biomolecules has been found to improve the clinical symptoms and severity of the coronavirus disease (COVID-19), with some indications of a preventive effect. In conclusion, these compounds may assist in preventing and/or improving the symptoms of COVID-19. Nevertheless, only limited evidence is available, and findings have been inconsistent. Further investigations are needed to verify the therapeutic potential of these supplements.
Reference178 articles.
1. Aimrane, A., Laaradia, M.A., Sereno, D., Perrin, P., Draoui, A., Bougadir, B., Hadach, M., Zahir, M., Fdil, N., and El Hiba, O. (2022). Insight into COVID-19’s Epidemiology, Pathology, and Treatment. Heliyon, 8. 2. (2024, August 03). World Health Organization. Coronavirus Disease (COVID-19). World Health Organization: Geneva, Switzerland. Available online: http://www.who.int/es/news-room/fact-sheets/detail/coronavirus-disease-(covid-19). 3. COVID-19 Outbreak: History, Mechanism, Transmission, Structural Studies and Therapeutics;Yesudhas;Infection,2021 4. Mouffak, S., Shubbar, Q., Saleh, E., and El-Awady, R. (2021). Recent Advances in Management of COVID-19: A Review. Biomed. Pharmacother., 143. 5. Tissue Distribution of ACE2 Protein, the Functional Receptor for SARS Coronavirus. A First Step in Understanding SARS Pathogenesis;Hamming;J. Pathol.,2004
|
|